Cancer Today, a quarterly magazine published by the American Association for Cancer Research has launched a new website, which is aimed at helping public find late-breaking news about cancer research, new cancer therapies, prevention strategies, and clinical trials.
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
